1. Home
  2. JXJT vs OGEN Comparison

JXJT vs OGEN Comparison

Compare JXJT & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXJT
  • OGEN
  • Stock Information
  • Founded
  • JXJT 2012
  • OGEN 1996
  • Country
  • JXJT China
  • OGEN United States
  • Employees
  • JXJT N/A
  • OGEN N/A
  • Industry
  • JXJT Apparel
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JXJT Consumer Staples
  • OGEN Health Care
  • Exchange
  • JXJT Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • JXJT 8.1M
  • OGEN 9.8M
  • IPO Year
  • JXJT 2012
  • OGEN N/A
  • Fundamental
  • Price
  • JXJT $1.34
  • OGEN $1.02
  • Analyst Decision
  • JXJT
  • OGEN
  • Analyst Count
  • JXJT 0
  • OGEN 0
  • Target Price
  • JXJT N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • JXJT 663.1K
  • OGEN 148.1K
  • Earning Date
  • JXJT 08-14-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • JXJT N/A
  • OGEN N/A
  • EPS Growth
  • JXJT N/A
  • OGEN N/A
  • EPS
  • JXJT 0.48
  • OGEN N/A
  • Revenue
  • JXJT $31,840,588.00
  • OGEN $20,629.00
  • Revenue This Year
  • JXJT N/A
  • OGEN N/A
  • Revenue Next Year
  • JXJT N/A
  • OGEN N/A
  • P/E Ratio
  • JXJT $2.78
  • OGEN N/A
  • Revenue Growth
  • JXJT N/A
  • OGEN N/A
  • 52 Week Low
  • JXJT $1.04
  • OGEN $0.97
  • 52 Week High
  • JXJT $8.51
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • JXJT 54.99
  • OGEN 35.55
  • Support Level
  • JXJT $1.20
  • OGEN $1.00
  • Resistance Level
  • JXJT $1.33
  • OGEN $1.19
  • Average True Range (ATR)
  • JXJT 0.23
  • OGEN 0.07
  • MACD
  • JXJT -0.00
  • OGEN 0.02
  • Stochastic Oscillator
  • JXJT 26.44
  • OGEN 6.25

About JXJT JX Luxventure Limited

JX Luxventure Ltd is engaged in the business of menswear, cross-border merchandise, airfare, and tourism. The company operates in three segments Tourism products, Technology and Cross- board merchandise. The majority of the group revenue is generated from the Tourism products.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: